课题基金 / 基金详情

Asymmetric C-C Bond-Forming Reactions Catalyzed by Cinchona Alkaloid Derivatives

Asymmetric C-C Bond-Forming Reactions Catalyzed by Cinchona Alkaloid Derivatives
金鸡纳生物碱衍生物催化的不对称 C-C 键形成反应
批准号:
7981266
负责人:
Michael Arthur Calter
金额:
$47.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-15 至 2015-01-31

项目摘要

项目成果

Michael Arthur Calter的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Most of the drugs used to treat the diseases plaguing mankind are made, or synthesized, by humans, rather than being isolated from natural source. Therefore, it is very important to keep developing new reactions for synthesizing "drug- like" molecules, likely to have beneficial activity. This proposal describes an investigation of a series of reactions, all related to one particular reaction, the "interrupted" Feist-Benary (IFB) reaction. These reactions generate molecular structures present in a number of molecules that have the potential to treat such conditions as fungal, bacterial and viral infections, along with some forms of cancer. Furthermore, these reactions control the chirality of these molecular structures. Chirality is a property associated with the three-dimensional shape of a molecule and is fundamental in determining how a molecule interacts with a biological system. It is also particularly difficult to control the chirality of a product, but the IFB and related reactions very effectively do this for the creation of the drug-like molecular structures. The proposal describes plans for discovering new reactions, for testing how wide a variety of products the reactions can produce, and for using the reactions in the synthesis of several families of biologically active, potentially clincally active molecules. PUBLIC HEALTH RELEVANCE: This proposal describes the synthesis of several families of potential antifungal, antibiotic, antiviral, and anticancer agents. It is essential to develop new agents with all these activities, as fungi, bacteria and viruses are all developing resistance to existing drugs, and the existing anticancer agents have limited activity and potent side-effects.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Catalytic, asymmetric, aldol/O-conjugate addition sequence for the construction of highly substituted furanoids.
用于构建高度取代的呋喃类化合物的催化、不对称、羟醛/O-共轭加成序列。
DOI: 10.1021/acs.orglett.5b00154
发表时间: 2015
期刊: Organic letters
影响因子: 5.2
作者: [Calter,MichaelA, Korotkov,Alexander]
通讯作者: Korotkov,Alexander
DOI: 10.1021/ol201332u
发表时间: 2011-07-15
期刊: Organic letters
影响因子: 5.2
作者: [Calter MA, Li N]
通讯作者: Li N
DOI: 10.1021/ol2026697
发表时间: 2011-12-02
期刊: Organic letters
影响因子: 5.2
作者: [Calter MA, Korotkov A]
通讯作者: Korotkov A
The Catalytic, Asymmetric Interrupted Feist-Benary Reaction
  • 批准号:
    7127748
  • 项目类别:
  • 资助金额:
    $24.2万
  • 财政年份:
    2006
  • 负责人:
    Michael Arthur Calter
  • 依托单位:
NEW HIGHLY EFFICIENT ROUTES TO POLYKETIDES
  • 批准号:
    6196383
  • 项目类别:
  • 资助金额:
    $10.19万
  • 财政年份:
    1997
  • 负责人:
    Michael Arthur Calter
  • 依托单位:
NEW HIGHLY EFFICIENT ROUTES TO POLYKETIDES
  • 批准号:
    6124341
  • 项目类别:
  • 资助金额:
    $11.54万
  • 财政年份:
    1997
  • 负责人:
    Michael Arthur Calter
  • 依托单位:
NEW HIGHLY EFFICIENT ROUTES TO POLYKETIDES
国内基金
海外基金
Iboga alkaloids骨架导向的不对称串联反应构建吖庚环并[4,5-b]吲哚及其在全合成中的应用
  • 批准号:
    21801032
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2018
  • 负责人:
    陈惠渝
  • 依托单位: